-
Mashup Score: 4Bria-IMT Plus Checkpoint Inhibition Is Safe and Yields Clinical Benefit in Pretreated Metastatic Breast Cancer - 4 day(s) ago
Bria-IMT plus checkpoint inhibition showed a manageable safety profile and activity in metastatic breast cancer.
Source: www.onclive.comCategories: General Medicine NewsTweet
Treatment with Bria-IMT plus an immune checkpoint inhibitor demonstrated favorable safety, tolerability, and evidence of clinical benefit in heavily pretreated patients with metastatic #BreastCancer. @AACR #AACR25 #BCSM https://t.co/JhddIYLnsG https://t.co/Tne8Vgy8xQ